Four insights:
1. Xiphos-ZF is the first implant developed from a new biomaterial called Zfuze.
2. Zfuze is a load-bearing biomaterial that evokes a pro-reparative macrophage phenotype rather than a pro-inflammatory phenotype.
3. Paul Kraemer, MD, of Indiana Spine Group in Carmel is set to perform the first spinal surgery with Xiphos-ZF.
4. DiFusion will launch Xiphos-ZF in the fourth quarter.
More articles on devices:
Orthofix reports $40.5M loss & more: 7 device company notes
Price transparency, value-based care & bundles: Altair Health CEO aims to drive change in spine
Stryker receives FDA clearance for 3D-printed expandable interbody device — 4 things to know
